Old Dominion Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$537K Buy
9,076
+56
+0.6% +$3.69K 0.11% 113
2021
Q2
$603K Buy
9,020
+56
+0.6% +$3.65K 0.13% 111
2021
Q1
$566K Buy
8,964
+50
+0.6% +$3.11K 0.13% 109
2020
Q4
$553K Buy
8,914
+182
+2% +$11.2K 0.14% 108
2020
Q3
$526K Hold
8,732
0.15% 99
2020
Q2
$513K Buy
8,732
+1,000
+13% +$59.8K 0.16% 100
2020
Q1
$431K Hold
7,732
0.18% 96
2019
Q4
$496K Sell
7,732
-116
-1% -$6.64K 0.16% 110
2019
Q3
$398K Hold
7,848
0.13% 115
2019
Q2
$356K Buy
7,848
+416
+6% +$19.4K 0.12% 112
2019
Q1
$361K Buy
7,432
+300
+4% +$14.9K 0.12% 113
2018
Q4
$371K Hold
7,132
0.13% 118
2018
Q3
$443K Buy
+7,132
New +$423K 0.13% 116

Other funds holding BMY

Old Dominion Capital Management's BMY Position: Q3 2021 in Review

Old Dominion Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.62% in Q3 2021, buying an estimated $3.69K and bringing the position to 9,076 shares worth $537K. The position accounts for 0.11% of the portfolio, ranked #113.

Old Dominion Capital Management first reported a position in BMY in Q3 2018 and has held it in 13 quarters since. The position peaked at $603K in Q2 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Old Dominion Capital Management held 9,076 shares of Bristol-Myers Squibb worth $537K as of Q3 2021.
  • Old Dominion Capital Management bought 56 Bristol-Myers Squibb shares in Q3 2021, an estimated $3.69K.
  • Bristol-Myers Squibb made up 0.11% of Old Dominion Capital Management's portfolio in Q3 2021, its #113 holding.
  • Old Dominion Capital Management first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 13 quarters since.
  • Old Dominion Capital Management's Bristol-Myers Squibb position peaked at $603K in Q2 2021.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Old Dominion Capital Management's 13F filing for Q3 2021, filed 8 Oct 2021.